• / Free eNewsletters & Magazine
  • / My Account
Home>In Vitro Toxicology Testing Market by Products & Services, Toxicity Endpoints & Tests, Technology, Method & Industry - Forecast to 2022 - Research and Markets

In Vitro Toxicology Testing Market by Products & Services, Toxicity Endpoints & Tests, Technology, Method & Industry - Forecast to 2022 - Research and Markets

In Vitro Toxicology Testing Market by Products & Services, Toxicity Endpoints & Tests, Technology, Method & Industry - Forecast to 2022 - Research and Markets

10/03/2017

In Vitro Toxicology Testing Market by Products & Services, Toxicity Endpoints & Tests, Technology, Method & Industry - Forecast to 2022 - Research and Markets

The "In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (ADME, Skin, Genotoxicity, Organ Toxicity), Technology, Method (Cellular Assays, Ex-Vivo), Industry (Pharmaceutical, Cosmetics) - Forecast to 2022" report has been added to Research and Markets' offering.

The In vitro toxicology testing market is projected to reach USD 8.74 Billion by 2022 from USD 6.34 Billion in 2017, at a CAGR of 6.6%.

The key factors driving the growth of this market include opposition to animal testing, growing demand for in vitro technology in the European market, new and promising technologies, and increasing R&D expenditure to detect toxicity at an early stage. On the other hand, failure to establish intricacies of in vivo conditions through in vitro, lack of in vitro models to study complex endpoints, and a dearth of skilled professionals are the major factors restraining the growth of this market.

The US is expected to hold the largest share of the global in vitro toxicology testing market in 2017, while China is expected to witness the highest growth during 2017 to 2022. Growing R&D investments in the biopharmaceutical sector, coupled with the rising number of CROs in this country contribute to the growth of this market in China. Additionally, rising international pressure on Chinese cosmetics industry to ban animal testing is expected to further drive this market.

Companies Mentioned

  • Ascendance Biotechnology, Inc.
  • Bio-Rad Laboratories, Inc.
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • Covance, Inc. (A Part of Laboratory Corporation of America Holdings)
  • Cyprotex Plc (A Subsidiary of Evotec Ag)
  • Eurofins Scientific Se
  • Ge Healthcare
  • Gentronix Limited
  • MB Research Laboratories
  • Merck Kgaa
  • Promega Corporation
  • Qiagen N.V.
  • SGS S.A.
  • Thermo Fisher Scientific

Key Topics Covered:

1 Introduction

©2017 Morningstar Advisor. All right reserved.